Stay updated on GTX-102 Safety in Angelman Syndrome Kids Clinical Trial
Sign up to get notified when there's something new on the GTX-102 Safety in Angelman Syndrome Kids Clinical Trial page.

Latest updates to the GTX-102 Safety in Angelman Syndrome Kids Clinical Trial page
- Check3 days agoChange DetectedThe web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check46 days agoChange DetectedThe web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check53 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to January 31, 2025.SummaryDifference1.0%
- Check96 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check110 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
Stay in the know with updates to GTX-102 Safety in Angelman Syndrome Kids Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GTX-102 Safety in Angelman Syndrome Kids Clinical Trial page.